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Background.  Classical monogenic familial hypercholesterolaemia (FH) is caused by mutations in the 
LDL metabolic pathway involving LDLR, APOB and PCSK9 genes.  Genetic testing for variants in these 
genes as part of the Wales FH Testing Service identifies pathogenic mutations in only 25% index 
patients.  It has recently been reported that patients with Cholesteryl Ester Storage Disease (CESD) 
may present with a lipid profile resembling that of FH, though the more classical presentation is with 
a mixed hyperlipidaemia and disturbed liver function tests in childhood.  CESD is a recessive disorder 
with a phenotype that is expressed in homozygous or compound heterozygote individuals. The most 
common CESD mutation is an exon 8 splice junction mutation in the LIPA gene (c.894G>A;E8SJM) 
which was found to have an allele frequency of 0.0011 (1 in 450 individuals) in a large  European 
population. No population estimate is available for the United Kingdom.  We sought to determine 
the prevalence of this mutation in patients in whom the common FH causing mutations had been 
ruled out. 
Method.  993 patients in whom the standard FH mutations had not been found were invited to 
participate in the study.  Of these, 545 patients provided informed, written consent.  Stored DNA 
samples from these patients were genotyped for the E8SJM mutation. 
Results.  Three heterozygotes were identified (allele frequency 0.0028).  Whole gene sequencing of 
the LIPA gene was undertaken in these 3 individuals, but no other mutations were found.  Therefore 
there were no CESD patients (homozygote or compound heterozygote) in this cohort.  
Conclusion The allele frequency 0.0028 (1 in 182 individuals) for the E8SJM mutation was marginally 
more prevalent in this cohort than in the European population study, but no cases of CESD 
(homozygotes) were detected. 
